REGN vs WS · P/E 14, rev $14.34B vs P/E 16, rev $3.09B
Regeneron Pharmaceuticals Inc (REGN) versus Worthington Steel Inc (WS) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Worthington Steel Inc (WS) is a steel company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported WS revenue for 2025-05-31 was $3.09B. Net income was $119.3M. Revenue was down 9.8% from 2024-05-31 to 2025-05-31. WS currently screens at market cap $1.99B and trailing P/E 16.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. WS currently screens at market cap $1.99B and trailing P/E 16.3.
Not investment advice. Open the REGN and WS stock pages for the full models.
Not investment advice.